Pentoxifylline
Pentoxifylline is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand name including Pentoxifylline. Available dosage forms: powder, tablet, extended release.
Drug Details
- Generic Name
- Pentoxifylline
- Brand Names
- Pentoxifylline
- Application Number
- ANDA074425
- Sponsor
- Medisca Inc.
- NDC Codes
- 7
- Dosage Forms
- POWDER, TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- PENTOXIFYLLINE
Indications and Usage
INDICATIONS & USAGE Pentoxifylline extended-release tablets are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. Pentoxifylline extended-release tablets can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease.